Charles Mowbray | BrazMedChem 2022 | Galoá Proceedings

Drugs for Nedlected Diseases initiative (DNDi)

Charles Mowbray

Is this your profile? Do login to access your certificates

Antitrypanosomal Benzoxazinone Series: Hit-to-Lead Campaign and Multiparametric Optimization
María Cruz Mollo ¹
Luiza Cruz ²
Marco Aurélio Dessoy ¹
Eun Lee ¹
Ramon Guerra de Oliveira ¹
Francielle Dutra ¹
Simone Duarte ³
Renata Krogh ³
Leonardo Luiz Gomes Ferreira ³
Rafael Chelucci ³
Clarissa Feltrin ³
Carolina Borsoi Moraes ⁴
Adriano D. Andricopulo ³
Jadel Kratz ⁵
Peter Sjö ²
Charles Mowbray ⁶
Luiz Carlos Dias ⁷
¹ Universidade Estadual de Campinas
² Drugs for Neglected Diseases initiative
³ Universidade de São Paulo
⁴ Universidade Federal de São Paulo
⁵ Drugs for Neglected Diseases initiative (DNDi)
⁶ Drugs for Nedlected Diseases initiative (DNDi)
⁷ UNICAMP
Vol 2, 2022 -
152552

2. Medicinal Chemistry of Synthetic Compounds

Oral

Co-authors (16)

Publications in other proceedings

BrazMedChem 2019
Antitrypanosomal aminobenzimidazoles: hit to lead expansion of new chemical entities against Trypanosoma cruzi and Leishmania infantum